Clinical outcomes and anticoagulation therapy in elderly non ‐valvular atrial fibrillation and heart failure patients

ConclusionsNon-valvular AF patients aged ≥75 years with a history of HF had higher risks of cardiovascular events and mortality. DOACs were favourable to warfarin regardless of the coexistence of HF. These results might encourage the use of DOACs in elderly patients with non-valvular AF with or without HF.

Source: ESC Heart Failure - January 12, 2024 Category: Cardiology Authors: Shota Ikeda, Ken ‐ichi Hiasa, Hiroshi Inoue, Takeshi Yamashita, Masaharu Akao, Hirotsugu Atarashi, Yukihiro Koretsune, Ken Okumura, Wataru Shimizu, Shinya Suzuki, Takanori Ikeda, Kazunori Toyoda, Atsushi Hirayama, Masahiro Yasaka, Takenori Tags: Original Article Source Type: research